Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
27.77
0.15 (0.54%)
At close: Aug 15, 2025, 3:59 PM
27.61
-0.55%
After-hours: Aug 15, 2025, 07:52 PM EDT
Apellis Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -228.17M | -223.68M | -197.88M | -250.1M | -332.89M | -417.27M | -528.63M | -606.04M | -657.08M | -691.01M | -652.17M | -634.11M | -638.42M | -701.63M | -746.35M | -520.16M | -460.29M | -359.71M |
Depreciation & Amortization | 1.8M | 1.8M | 1.8M | 1.84M | 1.79M | 1.75M | 1.7M | 1.64M | 1.59M | 1.53M | 1.49M | 1.44M | 1.35M | 1.46M | 1.49M | 1.17M | 1.22M | 889K |
Stock-Based Compensation | 108.36M | 111.15M | 114.13M | 114.03M | 108.18M | 107.47M | 105.94M | 103.97M | 105.88M | 99.14M | 91.08M | 86.16M | 79.81M | 75M | 70.67M | 63.85M | 58.75M | 52.52M |
Other Working Capital | -17.35M | 16.07M | 49.62M | 69.67M | 45.59M | 48.9M | 94.81M | 70.05M | 54.76M | 44.81M | 32.63M | 2.23M | -47M | -23.81M | -82.04M | -45.9M | 33.27M | -11.6M |
Other Non-Cash Items | 31.36M | 77.54M | 201.4M | 207.49M | 213.16M | 144.13M | 26.41M | 24.73M | 59.6M | 60.21M | 61.55M | 57.89M | 19.18M | 12.36M | 6.33M | 10.27M | 12.56M | 15.79M |
Deferred Income Tax | n/a | n/a | n/a | -133K | n/a | n/a | n/a | 133K | n/a | n/a | n/a | 55.19M | 120.51M | 141.69M | 198.26M | 183.16M | 115.14M | 91.19M |
Change in Working Capital | 91.14M | 95.37M | -18.53M | -89.44M | -209.73M | -267.88M | -200.17M | -162.03M | -132.94M | -49.66M | -15.7M | -52.06M | -82.14M | -50.26M | -93.52M | -46.95M | 32.77M | -6.14M |
Operating Cash Flow | 4.49M | -8.29M | -87.87M | -205.1M | -408.28M | -550.1M | -594.74M | -637.6M | -622.94M | -579.8M | -513.75M | -485.5M | -499.71M | -521.37M | -563.13M | -308.65M | -239.85M | -205.45M |
Capital Expenditures | -77K | -118K | -403K | -478K | -525K | -807K | -773K | -1.53M | -1.68M | -1.7M | -1.52M | -692K | -848K | -705K | -1.1M | -1.79M | -5.18M | -5.47M |
Cash Acquisitions | n/a | n/a | n/a | 99K | 99K | 99K | 99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 52.5M | 52.5M | 52.5M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 331.86M | 331.86M | n/a | -331.86M | -663.73M | -663.73M | -331.86M | -171.28M | -483.16M | -483.16M | -822.93M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 124.98M | 249.96M | 333.28M | 393.28M | 353.3M | 408.32M | 455M | 420M | 647.5M | 670M | 540M |
Other Investing Acitivies | n/a | n/a | n/a | 99K | 99K | 99K | 99K | -331.86M | -206.88M | 124.98M | -146.88M | 269.98M | 325M | 123.14M | 248.72M | 111.22M | 133.72M | 56.22M |
Investing Cash Flow | -77K | -118K | -403K | -379K | -426K | -708K | -674K | 123.45M | 248.28M | 331.58M | 59.89M | 20.74M | 75.61M | 122.43M | 247.62M | 162.54M | 181.66M | -235.9M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -200K | 322.87M |
Common Stock Repurchased | 5.41M | 3.22M | 3.22M | 3.22M | -13K | -41K | -41K | 4.2M | 3.21M | 2.7M | 2.7M | -1.54M | -897K | -595K | -1.55M | 24K | 385K | 619K |
Dividend Paid | n/a | n/a | n/a | -1.56M | -1.56M | -1.56M | -1.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.18M | 41.3M | 50.48M | 52.13M | 55.33M | 14.4M | 11.67M | -194K | 3.7M | -9.9M | -20.04M | -2.22M | -9.74M | 6.83M | 11.87M | 14.6M | 13.6M | -32.33M |
Financial Cash Flow | 5.37M | 41.3M | 149.24M | 149.33M | 152.53M | 111.61M | 394.5M | 382.47M | 386.36M | 380.06M | 365.66M | 765.56M | 758.05M | 767.31M | 392.24M | 14.6M | 13.4M | 290.54M |
Net Cash Flow | 10.04M | 32.8M | 60.31M | -55.26M | -255.92M | -439.33M | -200.78M | -131.95M | 11.59M | 131.34M | -88.68M | 300.14M | 333.42M | 368.03M | 74.71M | -131.51M | -46.26M | -151.91M |
Free Cash Flow | 4.41M | -8.41M | -88.27M | -205.58M | -408.81M | -550.9M | -595.51M | -639.13M | -624.61M | -581.5M | -515.27M | -486.19M | -500.56M | -522.08M | -564.23M | -310.44M | -245.03M | -210.92M |